Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer
BACKGROUND Aspirin reduces the incidence of colorectal adenoma and colorectal cancer among high-risk persons. Observational studies suggest that aspirin may also improve disease-free survival after diagnosis, particularly among patients with tumors harboring somatic PIK3CA mutations. However, data from randomized trials are lacking. METHODS We conducted a double-blind, randomized, placebo-controll
